Affimed
(OTC) AFMD
Affimed Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$877.00K
Net Income (TTM)
$69.97M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AFMD News
Why Shares of Affimed Fell Thursday
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Affimed
Industry
Biotechnology
Sector
Health CareEmployees
78
CEO
Shawn M. Leland, PharmD
Website
www.affimed.comHeadquarters
Mannheim, 69120, DE
AFMD Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-13%
Net Income Margin
-13%
Return on Equity
-1%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$8.28M
Operating Income
$106.66M
EBITDA
$102.38M
Operating Cash Flow
$110.27M
Capital Expenditure
$3.73M
Free Cash Flow
$114.00M
Cash & ST Invst.
$72.90M
Total Debt
$19.35M
Affimed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$155.00K
-92.1%
Gross Profit
$155.00K
-92.1%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
76
N/A
Net Income
$15.14M
+37.8%
EBITDA
$14.45M
+37.7%
Quarterly Fundamentals
Net Cash
$12.05M
-84.2%
Accounts Receivable
$4.54M
+85.7%
Inventory
$0.00
-100.0%
Long Term Debt
$5.99M
-58.8%
Short Term Debt
$6.90M
+5.6%
Return on Assets
-1.09%
N/A
Return on Invested Capital
-1.50%
N/A
Free Cash Flow
$11.14M
+48.1%
Operating Cash Flow
$11.13M
+39.0%